Sign up to save your podcasts
Or
Share MDT and patient perspectives on shared decision making for emerging treatment options
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MDT and patient perspectives on shared decision making for emerging treatment options
touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus a survivor of metastatic NSCLC, discuss the importance of involving patients in their treatment decisions and how clinicians can best support patients throughout their treatment journey.
The multidisciplinary team:
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/
View all episodes
By touchpodcasttouchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team, plus a survivor of metastatic NSCLC, discuss the importance of involving patients in their treatment decisions and how clinicians can best support patients throughout their treatment journey.
The multidisciplinary team:
- Medical Oncologist: Prof. Raffaele Califano, The Christie and Manchester University Hospital, Manchester, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/mdt-immunotherapies-for-metastatic-nsclc-without-driver-mutations/